BAWEI
837023
XI'AN WONDER
836419
Jiangsu Tiangong Technology
920068
4
Fujian Green Pine
300132
5
Yili Chuanning Biotechnology
301301
US Stock MarketDetailed Quotes
CODX Co-diagnostics
- 0.3445
- -0.0178-4.91%
Close May 14 16:00 ET
11.61MMarket Cap-0.29P/E (TTM)
0.4273High0.3210Low939.82KVolume0.3585Open0.3623Pre Close350.63KTurnover3.02%Turnover RatioLossP/E (Static)33.71MShares2.229952wk High0.24P/B10.71MFloat Cap0.280152wk Low--Dividend TTM31.08MShs Float30.9900Historical High--Div YieldTTM29.34%Amplitude0.2801Historical Low0.3730Avg Price1Lot Size
Co-diagnostics Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -80.11%50.28K | -42.53%3.92M | -95.80%149.33K | -73.91%641.14K | 1,243.15%2.66M | -58.01%252.75K | -80.09%6.81M | 153.67%3.56M | -51.77%2.46M | -96.06%197.81K |
| Operating revenue | -80.11%50.28K | -42.53%3.92M | -95.80%149.33K | -73.91%641.14K | 1,243.15%2.66M | -58.01%252.75K | -80.09%6.81M | 153.67%3.56M | -51.77%2.46M | -96.06%197.81K |
| Cost of revenue | -90.79%21.59K | -76.13%999.12K | -91.41%255.07K | 16.28%297.4K | -53.79%212.15K | -53.31%234.51K | -23.65%4.18M | 475.42%2.97M | -66.69%255.77K | -49.85%459.1K |
| Gross profit | 57.28%28.69K | 11.00%2.92M | -118.00%-105.74K | -84.38%343.74K | 1,035.63%2.44M | -81.71%18.24K | -90.86%2.63M | -33.69%587.34K | -49.12%2.2M | -106.36%-261.29K |
| Operating expense | -16.51%8.58M | -5.15%43M | -4.92%11.8M | -5.02%10.58M | -13.71%10.12M | 2.26%10.28M | 12.41%45.33M | 6.83%12.41M | 2.53%11.14M | 42.14%11.73M |
| Selling and administrative expenses | -23.48%3.43M | -2.36%20.64M | 12.10%6.64M | 5.84%5.35M | -23.38%4.17M | -5.04%4.48M | -2.16%21.14M | -10.02%5.92M | -8.35%5.05M | 38.22%5.45M |
| -Selling and marketing expense | -57.98%657.03K | -34.65%4.48M | -46.04%818.67K | -44.35%1.06M | -39.92%1.04M | -8.36%1.56M | -6.59%6.86M | 14.04%1.52M | 0.77%1.9M | 17.71%1.73M |
| -General and administrative expense | -4.99%2.77M | 13.15%16.16M | 32.13%5.82M | 36.20%4.29M | -15.66%3.13M | -3.16%2.92M | 0.12%14.28M | -16.12%4.4M | -13.10%3.15M | 50.46%3.71M |
| Research and development costs | -14.26%4.87M | -8.64%20.98M | -22.20%4.81M | -15.69%4.88M | -6.16%5.61M | 13.28%5.68M | 31.68%22.96M | 30.37%6.18M | 14.91%5.79M | 53.76%5.98M |
| Depreciation amortization depletion | -15.16%280.45K | 11.93%1.38M | 14.14%357.12K | 18.52%351.24K | 10.84%338.34K | 4.61%330.57K | -4.07%1.23M | 4.78%312.88K | -5.17%296.34K | -28.07%305.25K |
| -Depreciation and amortization | -15.16%280.45K | 11.93%1.38M | 14.14%357.12K | 18.52%351.24K | 10.84%338.34K | 4.61%330.57K | -4.07%1.23M | 4.78%312.88K | -5.17%296.34K | -28.07%305.25K |
| Other operating expenses | ---- | ---- | ---- | ---- | ---- | ---215.11K | ---- | ---- | ---- | ---- |
| Operating profit | 16.64%-8.55M | 6.15%-40.08M | -0.69%-11.91M | -14.54%-10.23M | 35.97%-7.68M | -3.10%-10.26M | -268.43%-42.71M | -10.18%-11.83M | -36.73%-8.94M | -189.23%-11.99M |
| Net non-operating interest income expense | -96.25%13.6K | -6.03%1.09M | -72.22%123.57K | -18.44%263.34K | 78.32%342.19K | 79.24%362.73K | 65.03%1.16M | 33.65%444.77K | 8.28%322.88K | 211.15%191.89K |
| Non-operating interest income | -96.25%13.6K | -6.03%1.09M | -72.22%123.57K | -18.44%263.34K | 78.32%342.19K | 79.24%362.73K | 65.03%1.16M | 33.65%444.77K | 8.28%322.88K | 211.15%191.89K |
| Other net income (expense) | 67.46%1.02M | -59.00%1.41M | 38.31%744.09K | -42.52%297.34K | -137.33%-240.95K | -64.95%607.38K | 143.14%3.43M | 103.67%537.99K | -81.27%517.3K | -1.85%645.4K |
| Gain on sale of security | 32.18%301.47K | -61.18%870.75K | -72.13%275.44K | -31.12%293.07K | -81.96%74.17K | -45.45%228.07K | --2.24M | --988.34K | --425.45K | --411.19K |
| Earnings from equity interest | 97.96%-1.44K | -284.77%-186.07K | -858.32%-53.29K | 127.65%12.68K | 40.49%-74.5K | -125.59%-70.96K | 130.24%100.7K | 92.69%-5.56K | 64.46%-45.87K | -17.52%-125.19K |
| Special income (charges) | 59.26%717.07K | -33.65%723.17K | 217.34%521.94K | -106.11%-8.41K | -166.95%-240.62K | -56.61%450.26K | 114.29%1.09M | 96.95%-444.79K | -95.24%137.72K | -52.96%359.41K |
| -Less：Restructuring and merger&acquisition | -59.26%-717.07K | 34.57%-714.88K | -217.06%-520.66K | 108.50%11.93K | 167.92%244.12K | 56.61%-450.26K | 86.17%-1.09M | 154.23%444.79K | 95.14%-140.3K | 55.78%-359.41K |
| -Gain on sale of property,plant,equipment | ---- | 421.61%8.29K | --1.28K | 236.27%3.51K | --3.5K | ---- | 98.13%-2.58K | --0 | -163.75%-2.58K | --0 |
| Income before tax | 19.03%-7.52M | 1.39%-37.58M | -1.82%-11.04M | -19.50%-9.67M | 32.07%-7.58M | -15.90%-9.29M | -102.21%-38.11M | 56.71%-10.84M | -132.93%-8.1M | -225.49%-11.16M |
| Income tax | -47.27%12K | 102.07%57.37K | -100.21%-8.18K | 101.05%22.19K | 100.92%20.59K | 101.01%22.76K | 39.73%-2.78M | 222.14%3.83M | 0.05%-2.11M | -201.86%-2.24M |
| Net income | 19.10%-7.53M | -6.53%-37.64M | 24.84%-11.03M | -62.09%-9.7M | 14.79%-7.6M | -61.80%-9.31M | -148.15%-35.33M | 33.00%-14.68M | -339.52%-5.98M | -232.01%-8.92M |
| Net income continuous Operations | 19.10%-7.53M | -6.53%-37.64M | 24.84%-11.03M | -62.09%-9.7M | 14.79%-7.6M | -61.80%-9.31M | -148.15%-35.33M | 33.00%-14.68M | -339.52%-5.98M | -232.01%-8.92M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 19.10%-7.53M | -6.53%-37.64M | 24.84%-11.03M | -62.09%-9.7M | 14.79%-7.6M | -61.80%-9.31M | -148.15%-35.33M | 33.00%-14.68M | -339.52%-5.98M | -232.01%-8.92M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 19.10%-7.53M | -6.53%-37.64M | 24.84%-11.03M | -62.09%-9.7M | 14.79%-7.6M | -61.80%-9.31M | -148.15%-35.33M | 33.00%-14.68M | -339.52%-5.98M | -232.01%-8.92M |
| Basic earnings per share | 22.58%-0.24 | -3.33%-1.24 | 28.00%-0.36 | -60.00%-0.32 | 19.35%-0.25 | -55.00%-0.31 | -166.67%-1.2 | 27.54%-0.5 | -400.00%-0.2 | -287.50%-0.31 |
| Diluted earnings per share | 22.58%-0.24 | -3.33%-1.24 | 28.00%-0.36 | -60.00%-0.32 | 19.35%-0.25 | -55.00%-0.31 | -166.67%-1.2 | 27.54%-0.5 | -400.00%-0.2 | -287.50%-0.31 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
Market Insights
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀